#CancerBiomarkers
🧬 RNA m5C in cancer: ready for the clinic?
🔬 A new review in LabMed Discovery examines the measurement gap.
🎯 Key insights: assay limitations, reliable quantification & a roadmap to clinical validation.
🔗 doi.org/10.1016/j.lm...
#RNA #CancerBiomarkers
September 26, 2026 at 2:14 PM
New article published in @tcrtcancer.bsky.social shows how transcriptomic-based prognostic tests can improve recurrence risk prediction in papillary thyroid cancer. @journals.sagepub.com

Read the full article here: bit.ly/3ITzE1P

#ThyroidCancer #MolecularDiagnostics #CancerBiomarkers #OncoDaily
August 1, 2025 at 2:38 PM
🧬 New paper out in @Cancers_MDPI! We show that Regnase-1 is a prognostic biomarker in high-grade soft tissue sarcoma — favorable in UPS, but flipped in adjuvantly irradiated patients. Context matters! 👉 www.mdpi.com/2072-6694/18... #SarcomaResearch #CancerBiomarkers #Immunology
www.mdpi.com
April 29, 2026 at 12:39 PM
Discover how gut microbiome profiles are linked to colorectal cancer through metagenomic sequencing. Watch our webinar to explore microbial biomarkers and cancer pathways. bit.ly/4lXwOHr #Metagenomics #ColorectalCancer #MicrobiomeResearch #Genomics #CancerBiomarkers
August 5, 2025 at 7:41 AM
New article published in @tcrtcancer.bsky.social shows how transcriptomic-based prognostic tests can improve recurrence risk prediction in papillary thyroid cancer.
@journals.sagepub.com

Read the full article: bit.ly/3ITzE1P

#ThyroidCancer #MolecularDiagnostics #CancerBiomarkers #OncoDaily
August 1, 2025 at 2:46 PM
🧬 Today is Cancer Biomarker Awareness Day!

Cancer #biomarkertesting helps doctors match patients to best treatment based on the cancer’s unique biology. Ask your doctor about biomarker testing today! 

Learn more at biomarkersmatter.org.

#CancerBiomarkers | #CancerBiomarkerDay
November 13, 2025 at 4:02 PM
September 22, 2025 at 11:41 PM
New from the CAP-IT MGUS U54 Center @bcmhouston.bsky.social in Cancer Biomarkers:
The Polyclonal Plasma Cell (PolyPC) signature is a strong negative predictor of MGUS progression to multiple myeloma.
📖 doi.org/10.1177/1875...
#Myeloma #MGUS #CancerBiomarkers #Hematology #CAPITPublication
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
doi.org
July 14, 2025 at 7:58 PM
Daniel F. Hayes is the recipient of the 2026 ESMO Breast Cancer Award in recognition of his contributions to the #BreastCancer field, particularly in experimental therapeutics & #CancerBiomarkers. He will deliver his award lecture on 6 May at #ESMOBreast26.  
📌 https://ow.ly/QwN250YBFs6
April 7, 2026 at 8:00 AM
Discover how gut microbiome profiles are linked to colorectal cancer through metagenomic sequencing. Watch our webinar to explore microbial biomarkers and cancer pathways.

Watch here: https://bit.ly/4lXwOHr

#Metagenomics #ColorectalCancer #MicrobiomeResearch #Genomics #CancerBiomarkers
November 26, 2025 at 8:05 AM
Serum albumin & lymphocyte count can predict response to neoadjuvant FLOT in geriatric #GastricCancer patients.
Higher albumin = better response & survival.
Routine blood tests may guide smarter treatment in older patients.
#GeriatricOncology #CancerBiomarkers #Turkey #Türkiye #Oncology
May 12, 2025 at 2:13 PM
Demand for tumor markers drives the US Carcinoembryonic Antigen Market growth. Explore forecasts: www.marketresearchfuture.com/reports/us-c...
#CancerBiomarkers #Diagnostics
US Carcinoembryonic Antigen Market Size, Industry Growth - 2035
US Carcinoembryonic Antigen Market share register 306.05 USD Million in 2024, projected to grow 15.38% CAGR to reach USD Million 1475.76 during the forecast period 2025 - 2035.
www.marketresearchfuture.com
February 12, 2026 at 9:18 AM
Grateful to SSPAC for fostering collaboration and to PALEMA for supporting young researchers who are making a difference in Pancreatic Cancer Research.

#ResearchMatters #PancreaticCancer #CancerBiomarkers
June 18, 2025 at 11:21 AM
Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies

🔦 buff.ly/jhH0yQu

#CancerBiomarkers #PleuralMesothelioma #DNAmethylation
December 2, 2025 at 9:15 AM
DACT1 as a Potential Therapeutic Target in Gastric Cancer: Insights from Integrative Bioinformatics and Experimental Analysis

www.dl.begellhouse.com/journals/0ff...

#GastricCancerResearch #Bioinformatics #CancerBiomarkers #JEP
March 11, 2026 at 4:15 PM
New bladder cancer research: lncRNA FENDRR is a promising biomarker & therapeutic target, inhibiting progression through the miR-18a-5p/ESR1 axis. Low FENDRR = poor prognosis.

www.dl.begellhouse.com/journals/0ff...

#BladderCancer #lncRNA #CancerBiomarkers
January 13, 2026 at 4:58 PM
It's Cancer Biomarker Awareness Day, a time to recognize the crucial role biomarkers play in #cancercare! If you're at #AMPath2025, visit registration for a free Cancer Biomarker Awareness button. Thank you, Revolution Medicines, for providing the buttons and for your support!
November 13, 2025 at 2:00 PM
📘Read in #JExBio📘 Circulating Tumour DNA and Extracellular Vesicle-Associated DNA as Biomarkers for Cancer Detection: A Systematic Review and Meta-Analysis #extracellularvesicles #liquidbiopsy #cancerbiomarkers #evdna isevjournals.onlinelibrary.wiley.com/doi/epdf/10....
June 16, 2026 at 10:17 AM
A big thank you to all collaborators, patients, and funding organizations who made this work possible. #BladderCancer #UrothelialCarcinoma #OncologyResearch #PrecisionMedicine #CirculatingTumorDNA #CancerBiomarkers #ClinicalTrials #MSK
April 7, 2025 at 9:54 PM
LRPPRC is emerging as a pan-cancer biomarker linked to poor prognosis, immune evasion & drug resistance. #CancerBiomarkers #LRPPRC #PanCancer #PrecisionMedicine #Immunotherapy
July 9, 2025 at 12:09 PM